当前位置:首页 - 行情中心 - 晨光生物(300138) - 财务分析 - 现金流量表

晨光生物

(300138)

  

流通市值:46.16亿  总市值:55.99亿
流通股本:3.98亿   总股本:4.83亿

现金流量表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金7,591,161,036.985,058,450,186.963,352,339,818.761,878,730,359.98
收到的税费返还102,921,119.799,666,812.7299,609,472.9261,114,695.46
收到其他与经营活动有关的现金184,659,672.63158,577,895.5152,672,744.2727,453,205.89
经营活动现金流入的平衡项目0000
经营活动现金流入小计7,878,741,829.315,316,694,895.193,504,622,035.951,967,298,261.33
购买商品、接受劳务支付的现金7,568,768,067.63,296,300,133.062,202,749,271.811,599,602,962.86
支付给职工以及为职工支付的现金252,264,199.61189,378,670.95127,419,162.7968,676,421.15
支付的各项税费110,179,820.2890,508,447.6766,336,818.3349,034,304.37
支付其他与经营活动有关的现金170,344,701.79137,321,034.4175,032,754.1252,553,049.1
经营活动现金流出的平衡项目0000
经营活动现金流出小计8,101,556,789.283,713,508,286.092,471,538,007.051,769,866,737.48
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-222,814,959.971,603,186,609.11,033,084,028.9197,431,523.85
二、投资活动产生的现金流量:
收回投资收到的现金1,021,788,639.791,155,980,563.47888,291,807.47648,538,819
取得投资收益收到的现金38,572,939.8310,788,235.6413,232,282.2215,080,727.35
处置固定资产、无形资产和其他长期资产收回的现金净额16,655.5394,149.5394,149.53-
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,060,378,235.151,166,862,948.64901,618,239.22663,619,546.35
购建固定资产、无形资产和其他长期资产支付的现金149,537,086.88149,980,402.6483,394,374.3634,050,563.38
投资支付的现金1,337,369,151.29801,677,762.46548,175,676.63157,434,766.6
支付其他与投资活动有关的现金14,426,983.15---
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,501,333,221.32951,658,165.1631,570,050.99191,485,329.98
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-440,954,986.17215,204,783.54270,048,188.23472,134,216.37
三、筹资活动产生的现金流量:
取得借款收到的现金5,783,439,209.463,448,038,020.22,887,838,020.21,453,585,020.2
收到其他与筹资活动有关的现金-220,000,000-1,970,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计5,783,439,209.463,668,038,020.22,887,838,020.21,455,555,020.2
偿还债务支付的现金5,087,427,9593,643,082,9692,578,917,000812,000,000
分配股利、利润或偿付利息支付的现金174,848,426.65152,004,899.95129,278,342.9529,373,479.56
其中:子公司支付给少数股东的股利、利润793,517.8793,517.8793,517.8-
支付其他与筹资活动有关的现金417,362,455.29444,515,155.91321,849,396.36148,021,065.24
筹资活动现金流出平衡项目0000
筹资活动现金流出小计5,679,638,840.944,239,603,024.863,030,044,739.31989,394,544.8
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额103,800,368.52-571,565,004.66-142,206,719.11466,160,475.4
四、汇率变动对现金及现金等价物的影响-10,493,145.08-6,716,726.56-4,916,168.61-2,405,269.04
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-570,462,722.71,240,109,661.421,156,009,329.411,133,320,946.58
加:期初现金及现金等价物余额1,085,264,962.721,085,264,962.721,085,264,962.721,085,264,962.72
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额514,802,240.022,325,374,624.142,241,274,292.132,218,585,909.3
补充资料:
净利润77,957,113.49-93,790,702.64-
资产减值准备95,164,207.13-2,369,527.74-
固定资产和投资性房地产折旧157,696,415.82-78,680,188.34-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧157,696,415.82-78,680,188.34-
无形资产摊销8,969,905.84-7,856,874.98-
长期待摊费用摊销200,000.04-100,000.02-
处置固定资产、无形资产和其他长期资产的损失-4,887,839.58---
固定资产报废损失457,881.85-202,988.68-
公允价值变动损失5,111,280.46-6,447,474.73-
财务费用114,417,669.76-65,144,695.63-
投资损失-17,787,444.36--15,988,000.75-
递延所得税-14,036,732.47-2,483,724.93-
其中:递延所得税资产减少-12,171,171.29-2,623,242.89-
递延所得税负债增加-1,865,561.18--139,517.96-
存货的减少-670,569,278.44-758,240,342.27-
经营性应收项目的减少62,071,449.5-130,098,055.13-
经营性应付项目的增加-41,673,355.69--153,011,337.12-
其他--55,826,094.72-
现金的期末余额514,802,240.02-1,991,274,292.13-
减:现金的期初余额875,264,962.72-875,264,962.72-
加:现金等价物的期末余额--250,000,000-
减:现金等价物的期初余额210,000,000-210,000,000-
公告日期2025-04-082024-10-262024-08-272024-04-25
审计意见(境内)标准无保留意见
TOP↑